CTKB
Cytek Biosciences Inc.
Company Overview
| Mkt Cap | $432.56M | Price | $3.90 |
| Volume | 485.38K | Change | +2.09% |
| P/E Ratio | -71.9 | Open | $3.78 |
| Revenue | $200.5M | Prev Close | $3.82 |
| Net Income | $-6.0M | 52W Range | $2.37 - $7.63 |
| Div Yield | N/A | Target | $5.13 |
| Overall | 45 | Value | 60 |
| Quality | -- | Technical | 30 |
No chart data available
Stock Overview
Updated DailyCytek Biosciences Inc. (CTKB) is a leading Professional, Scientific, and Technical Services company in the Testing Laboratories industry, currently trading at $3.90 with a market capitalization of $432.56 million. The stock is in the lower portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows CTKB with a volume of 485K shares. The stock opened down 1.05% from yesterday's close of $3.82. Current analyst estimates project earnings of $-0.19 per share for this year, with next year targeting $-0.21.
CTKB demonstrates concerning technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including PAVM, PECN, PEYE, PACB.
Key investment considerations for CTKB include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 31.5%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 02:11 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CTKB | $3.90 | +2.1% | 485.38K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |